Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Ductal, Breast | 11 | 2023 | 1085 | 1.490 |
Why?
|
Breast Neoplasms | 48 | 2024 | 21009 | 1.290 |
Why?
|
Receptor, erbB-2 | 19 | 2024 | 2556 | 1.220 |
Why?
|
Li-Fraumeni Syndrome | 3 | 2020 | 117 | 0.780 |
Why?
|
DNA Copy Number Variations | 4 | 2024 | 2020 | 0.730 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 5 | 2023 | 926 | 0.700 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2509 | 0.670 |
Why?
|
Polymorphism, Single-Stranded Conformational | 5 | 2005 | 330 | 0.540 |
Why?
|
Professional Autonomy | 1 | 2017 | 171 | 0.510 |
Why?
|
Breast | 7 | 2024 | 1966 | 0.450 |
Why?
|
Nurse Practitioners | 1 | 2017 | 271 | 0.440 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 517 | 0.440 |
Why?
|
Genes, ras | 4 | 2005 | 653 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3638 | 0.390 |
Why?
|
Mutation | 16 | 2024 | 30044 | 0.350 |
Why?
|
BRCA1 Protein | 5 | 2024 | 1155 | 0.340 |
Why?
|
Receptors, Estrogen | 9 | 2020 | 2208 | 0.320 |
Why?
|
Breast Neoplasms, Male | 3 | 2020 | 219 | 0.300 |
Why?
|
Genes, p53 | 3 | 2012 | 712 | 0.300 |
Why?
|
BRCA2 Protein | 2 | 2024 | 804 | 0.290 |
Why?
|
DNA Mutational Analysis | 6 | 2015 | 4108 | 0.270 |
Why?
|
Pathology, Clinical | 2 | 2024 | 375 | 0.270 |
Why?
|
Carcinoma, Lobular | 2 | 2022 | 481 | 0.260 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2018 | 266 | 0.260 |
Why?
|
Polymerase Chain Reaction | 4 | 2005 | 6086 | 0.250 |
Why?
|
Biopsy, Needle | 2 | 2017 | 1626 | 0.240 |
Why?
|
Microdissection | 1 | 2005 | 151 | 0.240 |
Why?
|
Aniline Compounds | 2 | 2020 | 1069 | 0.230 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1089 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 698 | 0.220 |
Why?
|
Receptors, Progesterone | 5 | 2020 | 1129 | 0.210 |
Why?
|
Loss of Heterozygosity | 1 | 2024 | 662 | 0.200 |
Why?
|
Immunoconjugates | 2 | 2020 | 954 | 0.200 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2017 | 1125 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2020 | 11735 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9275 | 0.190 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11070 | 0.190 |
Why?
|
Female | 63 | 2024 | 392485 | 0.190 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 41 | 0.180 |
Why?
|
bcl-X Protein | 2 | 2020 | 410 | 0.180 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3873 | 0.180 |
Why?
|
Lasers | 1 | 2005 | 951 | 0.180 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2022 | 591 | 0.180 |
Why?
|
Primary Health Care | 1 | 2017 | 4685 | 0.170 |
Why?
|
Sulfonamides | 2 | 2020 | 1976 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5297 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2022 | 507 | 0.170 |
Why?
|
Gene Dosage | 1 | 2024 | 1218 | 0.170 |
Why?
|
Ketones | 1 | 2020 | 183 | 0.170 |
Why?
|
Furans | 1 | 2020 | 200 | 0.160 |
Why?
|
Humans | 81 | 2024 | 761326 | 0.160 |
Why?
|
Receptor, erbB-3 | 1 | 2020 | 143 | 0.160 |
Why?
|
Carcinoma | 3 | 2019 | 2328 | 0.160 |
Why?
|
Mammary Glands, Human | 1 | 2020 | 203 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
Antibodies, Monoclonal | 4 | 2020 | 9180 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 997 | 0.150 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 24 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 370 | 0.150 |
Why?
|
Heterozygote | 1 | 2024 | 2803 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2911 | 0.140 |
Why?
|
Cadherins | 2 | 2022 | 904 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2023 | 8527 | 0.140 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3588 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2020 | 1405 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2022 | 559 | 0.140 |
Why?
|
Germ-Line Mutation | 3 | 2019 | 1858 | 0.140 |
Why?
|
Paclitaxel | 3 | 2019 | 1732 | 0.130 |
Why?
|
Integrins | 1 | 2020 | 834 | 0.130 |
Why?
|
Nipples | 1 | 2018 | 229 | 0.130 |
Why?
|
Cell Line, Tumor | 12 | 2020 | 16966 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2017 | 308 | 0.130 |
Why?
|
Pathology, Surgical | 1 | 2016 | 151 | 0.130 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.120 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13635 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 581 | 0.120 |
Why?
|
Bile Duct Neoplasms | 1 | 2000 | 605 | 0.120 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 63 | 0.120 |
Why?
|
Menopause | 1 | 2022 | 1646 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5665 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1114 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2017 | 447 | 0.110 |
Why?
|
Azepines | 1 | 2016 | 329 | 0.110 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.110 |
Why?
|
Middle Aged | 30 | 2024 | 220774 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2060 | 0.110 |
Why?
|
Exons | 4 | 2010 | 2392 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 3590 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2016 | 347 | 0.110 |
Why?
|
Mucin-1 | 1 | 2017 | 539 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1994 | 0.100 |
Why?
|
Genes, erbB-2 | 1 | 2013 | 162 | 0.100 |
Why?
|
Epithelial Cells | 1 | 2024 | 3666 | 0.100 |
Why?
|
Carcinoma, Ductal | 1 | 2013 | 97 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1669 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1021 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1901 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1075 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2001 | 1157 | 0.100 |
Why?
|
Cytoskeletal Proteins | 1 | 1998 | 1342 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 535 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1600 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3489 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2556 | 0.090 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2011 | 94 | 0.090 |
Why?
|
Immunotherapy | 3 | 2022 | 4649 | 0.090 |
Why?
|
Codon | 3 | 2001 | 602 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2017 | 1605 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 496 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 903 | 0.090 |
Why?
|
Doxorubicin | 1 | 2017 | 2215 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4139 | 0.080 |
Why?
|
Ubiquitination | 1 | 2014 | 1006 | 0.080 |
Why?
|
Adult | 23 | 2022 | 221122 | 0.080 |
Why?
|
Lipids | 2 | 2018 | 3341 | 0.080 |
Why?
|
Aged | 23 | 2023 | 169179 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2001 | 2534 | 0.080 |
Why?
|
Mice | 15 | 2022 | 81474 | 0.080 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 304 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3448 | 0.080 |
Why?
|
Prognosis | 9 | 2024 | 29588 | 0.080 |
Why?
|
Neoplasms | 4 | 2024 | 22158 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1403 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3792 | 0.080 |
Why?
|
Phosphoproteins | 1 | 1998 | 2445 | 0.080 |
Why?
|
Phenotype | 2 | 2020 | 16603 | 0.080 |
Why?
|
Medical Errors | 1 | 2016 | 1260 | 0.080 |
Why?
|
DNA, Neoplasm | 3 | 2002 | 1745 | 0.080 |
Why?
|
Trans-Activators | 1 | 1998 | 2858 | 0.080 |
Why?
|
Colorectal Neoplasms | 3 | 2005 | 6901 | 0.070 |
Why?
|
Cell Proliferation | 6 | 2022 | 10431 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2823 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4576 | 0.070 |
Why?
|
Animals | 20 | 2022 | 168388 | 0.070 |
Why?
|
Transcription Factors | 4 | 2023 | 12122 | 0.070 |
Why?
|
Stem Cells | 1 | 2020 | 3521 | 0.070 |
Why?
|
Aged, 80 and over | 14 | 2020 | 58946 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2019 | 0.070 |
Why?
|
Palliative Care | 2 | 2020 | 3592 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2811 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2859 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2170 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2019 | 3512 | 0.070 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9414 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2021 | 3469 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17872 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6473 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1891 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2010 | 791 | 0.060 |
Why?
|
Phosphorylation | 5 | 2016 | 8312 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2468 | 0.060 |
Why?
|
Signal Transduction | 4 | 2020 | 23427 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5841 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2014 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2020 | 80575 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10191 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2549 | 0.060 |
Why?
|
Proteomics | 3 | 2022 | 3843 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2221 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 898 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2000 | 5363 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1959 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1825 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6815 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12972 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
Ploidies | 1 | 2002 | 284 | 0.050 |
Why?
|
Genetic Markers | 3 | 2003 | 2612 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 2 | 2015 | 1062 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2625 | 0.050 |
Why?
|
Mice, Obese | 1 | 2022 | 420 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11098 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2019 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2448 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5794 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2020 | 2453 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2022 | 748 | 0.050 |
Why?
|
Tumor Burden | 2 | 2019 | 1887 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4246 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 271 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9030 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2002 | 392 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12934 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 800 | 0.040 |
Why?
|
DNA | 3 | 2022 | 7216 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9474 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 359 | 0.040 |
Why?
|
Phosphatidate Phosphatase | 1 | 1999 | 20 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2004 | 3611 | 0.040 |
Why?
|
Dissection | 1 | 2001 | 298 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2017 | 5866 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 869 | 0.040 |
Why?
|
Diamines | 1 | 2019 | 60 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2018 | 1540 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 696 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14665 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
Abscess | 1 | 2002 | 606 | 0.040 |
Why?
|
Mastectomy | 2 | 2019 | 1822 | 0.040 |
Why?
|
Glycolipids | 1 | 1999 | 206 | 0.040 |
Why?
|
Esters | 1 | 1999 | 212 | 0.040 |
Why?
|
Mind-Body Therapies | 1 | 2021 | 279 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 867 | 0.040 |
Why?
|
alpha Catenin | 1 | 1998 | 37 | 0.040 |
Why?
|
Catenins | 1 | 1998 | 44 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 12982 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 1737 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 504 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2019 | 255 | 0.040 |
Why?
|
Sphingolipids | 1 | 1999 | 174 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 6178 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2004 | 7852 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 2804 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 1998 | 142 | 0.040 |
Why?
|
Protein Binding | 3 | 2016 | 9351 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1999 | 412 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 701 | 0.040 |
Why?
|
Lymphocytes | 2 | 2021 | 2610 | 0.040 |
Why?
|
Cysts | 1 | 2002 | 681 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 687 | 0.030 |
Why?
|
Recurrence | 3 | 2019 | 8470 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 784 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 349 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12710 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2017 | 313 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2019 | 385 | 0.030 |
Why?
|
Risk Management | 1 | 2020 | 558 | 0.030 |
Why?
|
Genes, Fungal | 1 | 1998 | 439 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3777 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5817 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 30 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1814 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7389 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1595 | 0.030 |
Why?
|
Culture Media | 1 | 2018 | 899 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2004 | 1420 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 203 | 0.030 |
Why?
|
Phosphates | 1 | 1999 | 770 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 122 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2217 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39108 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 15 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2458 | 0.030 |
Why?
|
Thyroid Nodule | 1 | 2002 | 764 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1740 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1624 | 0.030 |
Why?
|
Oleic Acid | 1 | 2014 | 92 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1141 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2075 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2413 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9534 | 0.030 |
Why?
|
Nanomedicine | 1 | 2017 | 290 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 1998 | 570 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2002 | 6332 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 808 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1783 | 0.030 |
Why?
|
Cell Cycle | 1 | 2022 | 2930 | 0.030 |
Why?
|
Exercise | 2 | 2021 | 5883 | 0.030 |
Why?
|
Rwanda | 1 | 2016 | 665 | 0.030 |
Why?
|
Melanocytes | 1 | 2017 | 509 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12449 | 0.030 |
Why?
|
Young Adult | 5 | 2020 | 59196 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 402 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 193 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2381 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 710 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1589 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1699 | 0.030 |
Why?
|
Ferric Compounds | 1 | 2014 | 378 | 0.030 |
Why?
|
beta Catenin | 1 | 1998 | 1040 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 1742 | 0.030 |
Why?
|
Nanotechnology | 1 | 2018 | 712 | 0.030 |
Why?
|
Bone Marrow | 1 | 2002 | 2909 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2022 | 2644 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2019 | 926 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20092 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 953 | 0.020 |
Why?
|
Male | 11 | 2024 | 360621 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 2 | 2003 | 2687 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 1188 | 0.020 |
Why?
|
United States | 2 | 2017 | 72317 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1771 | 0.020 |
Why?
|
Rats | 4 | 2022 | 23729 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8166 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4345 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13500 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2724 | 0.020 |
Why?
|
Cohort Studies | 4 | 2020 | 41440 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2242 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4286 | 0.020 |
Why?
|
Carboplatin | 1 | 2013 | 794 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4509 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1900 | 0.020 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 491 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17640 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1121 | 0.020 |
Why?
|
Mice, Nude | 1 | 2016 | 3603 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4173 | 0.020 |
Why?
|
Oncogenes | 1 | 2015 | 1223 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2003 | 6128 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6309 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2002 | 2332 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 2007 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1656 | 0.020 |
Why?
|
Necrosis | 2 | 2003 | 1605 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1998 | 1841 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 747 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 88305 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2605 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4908 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9605 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1611 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13446 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2985 | 0.020 |
Why?
|
Fatty Acids | 1 | 2014 | 1806 | 0.020 |
Why?
|
Databases, Factual | 1 | 2001 | 7954 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5768 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6052 | 0.020 |
Why?
|
Registries | 1 | 2001 | 8223 | 0.020 |
Why?
|
Muscles | 1 | 1990 | 1575 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4280 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5202 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2002 | 4175 | 0.010 |
Why?
|
Genetic Variation | 1 | 2020 | 6571 | 0.010 |
Why?
|
Genetic Testing | 1 | 2017 | 3538 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22154 | 0.010 |
Why?
|
Chromatin | 1 | 2016 | 2960 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2003 | 123 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3597 | 0.010 |
Why?
|
Nanoparticles | 1 | 2014 | 1955 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4423 | 0.010 |
Why?
|
Polyploidy | 1 | 2003 | 119 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11531 | 0.010 |
Why?
|
Time Factors | 2 | 2002 | 39974 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3793 | 0.010 |
Why?
|
Antioxidants | 1 | 1990 | 1670 | 0.010 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2002 | 61 | 0.010 |
Why?
|
Genome, Fungal | 1 | 2003 | 203 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7597 | 0.010 |
Why?
|
DNA, Fungal | 1 | 2003 | 275 | 0.010 |
Why?
|
Aging | 2 | 1991 | 8704 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2003 | 1306 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18962 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 451 | 0.010 |
Why?
|
Lipid Peroxides | 2 | 1991 | 74 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2003 | 629 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1084 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2002 | 225 | 0.010 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 330 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29858 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13355 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3455 | 0.010 |
Why?
|
Valine | 1 | 2001 | 408 | 0.010 |
Why?
|
Oxygen | 1 | 1991 | 4227 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15879 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1992 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74152 | 0.010 |
Why?
|
Automation | 1 | 2001 | 587 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54405 | 0.010 |
Why?
|
Myocardium | 1 | 1991 | 4723 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5706 | 0.010 |
Why?
|
Hydrolysis | 1 | 1999 | 665 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2002 | 718 | 0.010 |
Why?
|
Tamoxifen | 1 | 2002 | 965 | 0.010 |
Why?
|
Spodoptera | 1 | 1998 | 141 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 489 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1998 | 455 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 427 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 1999 | 576 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26211 | 0.010 |
Why?
|
Cell Line | 2 | 2003 | 15599 | 0.010 |
Why?
|
Lysophospholipids | 1 | 1999 | 338 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18234 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64645 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15719 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10203 | 0.010 |
Why?
|
Rabbits | 1 | 2002 | 4779 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36202 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1999 | 1793 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4567 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42251 | 0.010 |
Why?
|
Liver | 1 | 1990 | 7531 | 0.010 |
Why?
|
Age Factors | 2 | 2003 | 18401 | 0.010 |
Why?
|
Mutagenesis | 1 | 1998 | 1232 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3592 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2423 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2820 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2001 | 2570 | 0.010 |
Why?
|
Kinetics | 1 | 1999 | 6374 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8526 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 3734 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 1990 | 138 | 0.010 |
Why?
|
Citrate (si)-Synthase | 1 | 1990 | 48 | 0.010 |
Why?
|
Gene Deletion | 1 | 1998 | 2667 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1998 | 2914 | 0.010 |
Why?
|
Catalase | 1 | 1990 | 217 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3687 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1990 | 411 | 0.000 |
Why?
|
Glutathione Peroxidase | 1 | 1990 | 257 | 0.000 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1990 | 210 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10075 | 0.000 |
Why?
|
Child | 1 | 2017 | 80156 | 0.000 |
Why?
|
Glutathione Transferase | 1 | 1990 | 565 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12059 | 0.000 |
Why?
|
Superoxide Dismutase | 1 | 1990 | 592 | 0.000 |
Why?
|
Glycolysis | 1 | 1991 | 836 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36430 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 12450 | 0.000 |
Why?
|
Organ Size | 1 | 1991 | 2252 | 0.000 |
Why?
|
Calcium | 1 | 1999 | 5726 | 0.000 |
Why?
|
Muscle Proteins | 1 | 1991 | 1152 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1991 | 2229 | 0.000 |
Why?
|
Heart | 1 | 1991 | 4405 | 0.000 |
Why?
|